Laboratoire vivant PPI4MED sur les marchés publics de l´innovation : qu'est-ce que c'est, qui peut participer et comment ça marche?


Ce contenu est disponible uniquement en anglais

In the EU, the annual public procurement market for goods, services and works is valued at approximately 14% of EU GDP - roughly EUR 1,8 trillion annually - , therefore Government has the capacity to demand the production of innovative products and services. Market demand for new products and services has a strong influence on levels of R&D investment.

What is the Innovation Procurement Living lab?

The Livign lab is a platform for meeting and matching interests between public procurers (buyers), private companies (sellers) and national research centers (patents owners) to generate idea's technology solutions that can be materialised in potential public procurement of innovation (PPI) projects.

Its main characteristics are:

  • It is based on a recurrent and open model of exploration and co-generation of ideas and projects, where any entity with interest in PPI can participate.
  • It is an instrument to explore the best ideas to be transformed into specific PPI pilot proposals.
  • It is mainly focused to use innovation procrurement as an instrument to transfer research results from public R&D Centres.

Spain, Italy, Jordan, Tunisia and Egypt are working together in the creation of five national Living labs and putting together a Mediterranean Living Lab with regional key actors.

Which sectors are involved?

The Livin lab initiative is aligned with the European Green Deal mainly focused on sectors and activities related with environment and digital transformation in areas such as waste treatment, water management, energy efficiency, clean energy, ICT environmental solutions and health.

Who can participate in the living lab?

The main participants to actively participate in the Living lab are:

PUBLIC PROCURERS: Agents at all three levels of the public sector: national, regional and local:

  • Ministerial departments, public entities, public agencies, city councils, etc., with experience or interest in improving public services through innovation.
  • Other public entities with no experience in PPI, but can become public procurers of innovation.

SELLERS OF TECHNOLOGICAL SOLUTIONS:Private companies with the capacity to develop TRL4 to TRL9 products and solutions from patents.

  • Large companies.
  • SMEs.
  • Start-ups and technology-based companies.

NATIONAL RESEARCH CENTRES: researchers or representatives of the Technology Transfer Offices (TTOs), which might mobilize public research to face key challenges identified by public procurers and private companies.


Join in our Innovation Procurement Living lab initiative to discuss needs and challenges from the public demand.


Keep in touch with PPI4MED project on Twitter and Facebook!